Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance. | Front Microbiol;13: 841905, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance.

Schuch, Raymond; Cassino, Cara; Vila-Farres, Xavier.

Affiliation

Schuch R; ContraFect Corporation, Yonkers, NY, United States.
Cassino C; ContraFect Corporation, Yonkers, NY, United States.
Vila-Farres X; ContraFect Corporation, Yonkers, NY, United States.

Front Microbiol ; 13: 841905, 2022.

Article in En | MEDLINE | ID: mdl-35308352

Key words

antibiotic resistance; antimicrobial; biologic; cell wall hydrolase; lysin; peptides

Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Microbiol Year: 2022 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Microbiol Year: 2022 Type: Article Affiliation country: United States